ADA: No CV or Cancer Risk with Insulin (CME/CE, with video)
15:42 EDT 11 Jun 2012 | MedPageToday
PHILADELPHIA (MedPage Today) -- The longest trial to study insulin has concluded it has a neutral effect on cardiovascular outcomes and cancer incidence, researchers said.
Original Article: ADA: No CV or Cancer Risk with Insulin (CME/CE, with video)
More From BioPortfolio on "ADA: No CV or Cancer Risk with Insulin (CME/CE, with video)"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
